Siste måned
30 dager
0
NETTO POSISJON (NOK)
Handler
0
Kjøp
0
Salg
0
6 måneder
180 dager
0
NETTO POSISJON (NOK)
Handler
7
Kjøp
0
Salg
0
Historikk
ℹ️ Om innsidehandel
Primærinnsidere er personer med ledelsesansvar og deres nærstående. Meldeplikt inntrer når transaksjoner når EUR 5 000 i et kalenderår.
Meldefrist: umiddelbart, senest tre virkedager. Handelsforbud 30 dager før pliktig finansiell rapportering.
Transaksjoner
Mer info 👉
| Dato | Innsider | Antall | Pris | Verdi |
|---|---|---|---|---|
| 20.05.2026 |
Kari Grønås
Board member
|
854 | - | - |
| 20.05.2026 |
Hilde Steineger
Board member
|
854 | - | - |
| 20.05.2026 |
Johan Häggblad
Board member
|
854 | - | - |
| 20.05.2026 |
Olav Hellebø
Board member
|
1 408 | - | - |
| 20.05.2026 |
Orlando Oliveira
Board member
|
854 | - | - |
| 20.05.2026 |
Charles Gillies O'Bryan-Tear
Chairperson of the Board
|
1 708 | - | - |
| 11.03.2026 |
Øystein Soug
CEO
|
31 884 | - | - |
| 12.01.2026 |
Ramzi Amri
CFO
|
5 430 000 | 0.50 | 2 715 000 |
Pressemeldinger
| Dato | Melding |
|---|---|
| 20.05.2026 |
Oncoinvent ASA: Grant of share options to member of the Board following AGM
Oslo, Norway, 20 May 2026: Reference is made to the Annual General Meeting (the
"AGM") of Oncoinvent ASA (the "Company") earlier today where the nomin...
|
| 11.03.2026 |
Oncoinvent ASA: Grant of share options to the CEO
Oslo, Norway, 11 March 2026: The Board of Directors has today resolved to grant
CEO Øystein Soug 31,884 share options in the Company under the Company...
|
| 13.01.2026 |
Oncoinvent ASA: Grant of share options to new CFO
Oslo, Norway, 13 January 2026: Reference is made to the announcement made by
Oncoinvent ASA ("Oncoinvent" or the "Company") 31 October 2025 regarding ...
|